Literature DB >> 4587069

Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.

A Raskin, J G Schulterbrandt, N Reatig, T H Crook, D Odle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4587069     DOI: 10.1001/archpsyc.1974.01760070050008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  13 in total

Review 1.  Benzodiazepines. Depressants or antidepressants?

Authors:  J W Tiller; I Schweitzer
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

2.  Editorial: New look at monoamine oxidase inhibitors.

Authors: 
Journal:  Br Med J       Date:  1976-07-10

3.  Complications of Intravenous Diazepam - Adverse Psychological Reactions. (An assessment of 16,000 cases).

Authors:  N B Litchfield
Journal:  Anesth Prog       Date:  1980-11

Review 4.  Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.

Authors:  H J Möller; H P Volz
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

5.  Comparative double-blind trial of mianserin hydrochloride (Organon GB94) and diazepam in patients with depressive illness.

Authors:  G F Russell; U Niaz; A Wakeling; P D Slade
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

6.  Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

7.  Strategies for the drug treatment of depression.

Authors:  A J Cooper; R V Magnus
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

8.  Some considerations on the role of benzodiazepines in the treatment of depression.

Authors:  G B Cassano; L Conti
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

9.  The Zurich Study. VI. A continuum from depression to anxiety disorders?

Authors:  J Angst; A Dobler-Mikola
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 10.  Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors.

Authors:  Y Lecrubier
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.